She is focused on reducing Adverse Drug Events (ADRs) which are the 4th leading cause of death in the US after all cancers (128,00+/year).
FT. LAUDERDALE, FL, June 11, 2024 /24-7PressRelease/ -- Cathy L. Cather has been recognized for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Ms. Cather has established a distinguished career in health care innovation, having served as CEO of Parallel Profile since 2016. In this role, she handles all functional operations and vision strategies for the company. She is focused on reducing Adverse Drug Events (ADRs) which are the 4th leading cause of death in the US after all cancers (128,00+/year). To put it in perspective, there's 3 times as many deaths from ADRs as from breast cancer) and more than from pulmonary disease, diabetes, AIDS, pneumonia, accidents, and automobile deaths. Parallel Profile provides DNA testing and telemedicine consults by certified specialists to help patients and their providers understand how their DNA and interactions with all the prescription and over the counter drugs they are taking impact both the safety and effectiveness of drugs they are considering.
Before her tenure at Parallel Testing, she was the chief executive officer at Cather Consulting from 2008 to 2016, where she identified and championed meaningful health care start ups who deserved to win like Quantum Health, Pinnacle Care, TeleDoc, One Medical, Aetna Meritain, 2ndMd, and others who greatly improve patient outcomes.
Before launching her entrepreneurial endeavors, Ms. Cather honed her leadership skills as an executive vice president at several companies, including Accolade, HealthEquity Inc., and at the UnitedHealth Group. Her career also includes pivotal roles as a national practice leader at Towers Perrin and a senior vice president and practice leader of integrated benefits at Aon. She also created and raised the funding for the non profit research organization, the Integrated Benefit Institute, further underscoring her commitment to improving health outcomes.
Ms. Cather's expertise in health care innovation is widely recognized throughout the industry. She is very proud of having been named among the Forbes Top 52 Female-Led Startups and included as one of the Top 10 Most Innovative Healthcare Companies by the Employer Health Innovation Roundtable. Her dedication to creating impactful health care solutions is evident through her outstanding work, particularly in advocating for pharmacogenetic testing, a process that evaluates genetic predispositions to adverse drug reactions.
She attributes her success in the industry to a combination of curiosity, an adventurous spirit, and a rich family history of innovation and academic excellence.
Beyond her professional life, Ms. Cather enjoys scuba diving, and world travel having visited over 100 countries. Looking ahead, she is committed to significantly reducing adverse drug reactions in the United States through widespread pharmacogenetic testing. As a racially diverse American, her personal experiences play a crucial role in shaping her perspectives and goals on the critical need to take a scientific approach to racial health equity based on the reality of genetics and not on how people look.
About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.
# # #